139 related articles for article (PubMed ID: 12805328)
1. Soluble E-cadherin is an independent pretherapeutic factor for long-term survival in gastric cancer.
Chan AO; Chu KM; Lam SK; Wong BC; Kwok KF; Law S; Ko S; Hui WM; Yueng YH; Wong J
J Clin Oncol; 2003 Jun; 21(12):2288-93. PubMed ID: 12805328
[TBL] [Abstract][Full Text] [Related]
2. Early prediction of tumor recurrence after curative resection of gastric carcinoma by measuring soluble E-cadherin.
Chan AO; Chu KM; Lam SK; Cheung KL; Law S; Kwok KF; Wong WM; Yuen MF; Wong BC
Cancer; 2005 Aug; 104(4):740-6. PubMed ID: 15991243
[TBL] [Abstract][Full Text] [Related]
3. Influence of age on soluble E-cadherin serum levels prevents its utility as a disease marker in gastric cancer patients.
Pedrazzani C; Caruso S; Corso G; Marrelli D; Neri A; Berardi A; Roviello F
Scand J Gastroenterol; 2008; 43(6):765-6. PubMed ID: 18569997
[No Abstract] [Full Text] [Related]
4. E-cadherin expression as predictive marker of proximal resection line involvement for advanced carcinoma of the gastric cardia.
Polkowski WP; Skomra DG; Mielko J; Wallner GT; Szumiło J; Zinkiewicz K; Korobowicz EM; van Lanschot JJ
Eur J Surg Oncol; 2004 Dec; 30(10):1084-92. PubMed ID: 15522555
[TBL] [Abstract][Full Text] [Related]
5. Soluble E-cadherin is a valid prognostic marker in gastric carcinoma.
Chan AO; Lam SK; Chu KM; Lam CM; Kwok E; Leung SY; Yuen ST; Law SY; Hui WM; Lai KC; Wong CY; Hu HC; Lai CL; Wong J
Gut; 2001 Jun; 48(6):808-11. PubMed ID: 11358900
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of serum soluble E-cadherin in colorectal carcinoma.
Okugawa Y; Toiyama Y; Inoue Y; Iwata T; Fujikawa H; Saigusa S; Konishi N; Tanaka K; Uchida K; Kusunoki M
J Surg Res; 2012 Jun; 175(2):e67-73. PubMed ID: 22277332
[TBL] [Abstract][Full Text] [Related]
7. Positive association of up-regulated Cripto-1 and down-regulated E-cadherin with tumour progression and poor prognosis in gastric cancer.
Zhong XY; Zhang LH; Jia SQ; Shi T; Niu ZJ; Du H; Zhang GG; Hu Y; Lu AP; Li JY; Ji JF
Histopathology; 2008 Apr; 52(5):560-8. PubMed ID: 18312357
[TBL] [Abstract][Full Text] [Related]
8. Aerodigestive tract invasion by well-differentiated thyroid carcinoma: diagnosis, management, prognosis, and biology.
McCaffrey JC
Laryngoscope; 2006 Jan; 116(1):1-11. PubMed ID: 16481800
[TBL] [Abstract][Full Text] [Related]
9. Soluble intercellular adhesion molecule-1 as a prognostic marker for stage II colorectal cancer patients.
Toiyama Y; Miki C; Inoue Y; Okugawa Y; Koike Y; Yokoe T; Tanaka K; Kusunoki M
Ann Surg Oncol; 2008 Jun; 15(6):1617-24. PubMed ID: 18368454
[TBL] [Abstract][Full Text] [Related]
10. Serum TIMP-1 in gastric cancer patients: a potential prognostic biomarker.
Wang CS; Wu TL; Tsao KC; Sun CF
Ann Clin Lab Sci; 2006; 36(1):23-30. PubMed ID: 16501233
[TBL] [Abstract][Full Text] [Related]
11. Disseminated tumor cells in the blood of patients with gastric cancer are an independent predictive marker of poor prognosis.
Illert B; Fein M; Otto C; Cording F; Stehle D; Thiede A; Timmermann W
Scand J Gastroenterol; 2005 Jul; 40(7):843-9. PubMed ID: 16109661
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of receptor-binding cancer antigen expressed on SiSo cells (RCAS1) expression in relation to cadherin expression in patients with colorectal carcinoma.
Tsujitani S; Saito H; Honboh T; Ataka M; Tanida T; Makino M; Ikeguchi M
Dis Colon Rectum; 2007 Aug; 50(8):1241-9. PubMed ID: 17429708
[TBL] [Abstract][Full Text] [Related]
13. Preoperative plasma level of IL-10 but not of proinflammatory cytokines is an independent prognostic factor in patients with gastric cancer.
Szaflarska A; Szczepanik A; Siedlar M; Czupryna A; Sierzega M; Popiela T; Zembala M
Anticancer Res; 2009 Dec; 29(12):5005-12. PubMed ID: 20044609
[TBL] [Abstract][Full Text] [Related]
14. Potential diagnostic and prognostic values of detecting promoter hypermethylation in the serum of patients with gastric cancer.
Leung WK; To KF; Chu ES; Chan MW; Bai AH; Ng EK; Chan FK; Sung JJ
Br J Cancer; 2005 Jun; 92(12):2190-4. PubMed ID: 15942635
[TBL] [Abstract][Full Text] [Related]
15. Significance of the serum level of soluble E-cadherin in patients with HCC.
Soyama A; Eguchi S; Takatsuki M; Kawashita Y; Hidaka M; Tokai H; Nagayoshi S; Mochizuki S; Matsumoto S; Hamasaki K; Tajima Y; Kanematsu T
Hepatogastroenterology; 2008; 55(85):1390-3. PubMed ID: 18795696
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of E-cadherin protein expression in pathological stage I-III endometrial cancer.
Mell LK; Meyer JJ; Tretiakova M; Khramtsov A; Gong C; Yamada SD; Montag AG; Mundt AJ
Clin Cancer Res; 2004 Aug; 10(16):5546-53. PubMed ID: 15328195
[TBL] [Abstract][Full Text] [Related]
17. Gastric neuroendocrine carcinoma: clinicopathologic review and immunohistochemical study of E-cadherin and Ki-67 as prognostic markers.
Boo YJ; Park SS; Kim JH; Mok YJ; Kim SJ; Kim CS
J Surg Oncol; 2007 Feb; 95(2):110-7. PubMed ID: 17066436
[TBL] [Abstract][Full Text] [Related]
18. [Correlation of preoperative serum vascular endothelial growth factor level with CA125 level in patients with epithelial ovarian cancer and its prognostic value].
Tan XJ; Lang JH; Shen K; Wang L; Wu M; Xu XY
Zhonghua Fu Chan Ke Za Zhi; 2008 Jan; 43(1):9-12. PubMed ID: 18366924
[TBL] [Abstract][Full Text] [Related]
19. Tissue microarray analysis of the prognostic value of E-cadherin, Ki67, p53, p27, survivin and MSH2 expression in upper urinary tract transitional cell carcinoma.
Fromont G; Rouprêt M; Amira N; Sibony M; Vallancien G; Validire P; Cussenot O
Eur Urol; 2005 Nov; 48(5):764-70. PubMed ID: 16126329
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of dysadherin expression in patients with non-small cell lung cancer.
Tamura M; Ohta Y; Tsunezuka Y; Matsumoto I; Kawakami K; Oda M; Watanabe G
J Thorac Cardiovasc Surg; 2005 Sep; 130(3):740-5. PubMed ID: 16153922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]